Kuros Biosciences AG
CSBTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,013 | -$3,709 | -$211 | -$8,675 |
| Dep. & Amort. | $0 | $1,358 | $1,278 | $1,339 |
| Deferred Tax | $0 | $0 | $0 | -$7,034 |
| Stock-Based Comp. | $2,729 | $2,199 | $2,928 | $400 |
| Change in WC | -$8,040 | $1,149 | -$4,454 | -$10 |
| Other Non-Cash | $4,647 | $2,459 | $143 | $11,881 |
| Operating Cash Flow | -$2,677 | $3,456 | -$316 | -$2,099 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,068 | -$498 | -$597 | -$235 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$17 | $1 |
| Investing Cash Flow | -$1,068 | -$498 | -$614 | -$234 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$379 | $0 | -$335 | $0 |
| Stock Issued | $0 | $287 | $1,654 | $501 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,215 | -$1,132 | $863 | $138 |
| Financing Cash Flow | $836 | $809 | $528 | $138 |
| Forex Effect | $1,589 | -$23 | $471 | -$230 |
| Net Chg. in Cash | $18,442 | $3,744 | $69 | -$2,653 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $14,277 | $14,208 | $16,861 |
| End Cash | $18,442 | $18,021 | $14,277 | $14,208 |
| Free Cash Flow | -$3,745 | $2,941 | -$913 | -$2,334 |